MDx Impact Grants – RIPO KMUTT

The MDx Impact Grants aim to unlock the potential of PCR to democratise access to accurate diagnostic tests that improve patient outcomes. The programme provides researchers with access to Seegene’s syndromic PCR technology and development grants to perform clinical studies.

Funding Organization: Nature In partnership with Seegene

Scope: The 2026 MDx Impact Grants focus on molecular markers associated with neurodegenerative disease, with a specific focus on Alzheimer’s disease.

Eligibility: Applications are open to eligible research groups worldwide. Research groups are required to have access to BSL-2 (Biosafety level 2) facilities, experience in PCR, access to relevant clinical specimens and eligibility to conduct clinical studies for in vitro diagnostic (IVD) validation in accordance with applicable regulatory requirements.

Awards: The programme provides researchers with access to Seegene’s syndromic PCR technology and development grants of up to 600,000 USD to perform clinical studies.

Application Process: Applications must be submitted online through https://natureawards.submittable.com/submit/55e4fff5-032f-4b88-8888-ec867108e9fa/mdx-impact-grants-2026-2027/

Application Deadline: 19 November 2026

Further information: https://www.nature.com/immersive/mdximpactgrants/index.html

————————————————

For more information, please contact

Ms. Panida Suwannatheerak and Ms. Mananchaya Pissaparn

Tel. 0-2470-9654

Email: researchfollowup@kmutt.ac.th